MedTrace Logo

Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

NCT01609855 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2012-06-01

No results posted yet for this study

Summary

The primary aim of the study was to test if the administration of Hyoscine Butyl Bromide, at time of caecal intubation, increases the adenoma detection rate.

Conditions

  • Colonic Adenomas

Interventions

DRUG

Hyoscine Butyl Bromide 20mg/2 ml i.v.

Hyoscine Butyl Bromide 20mg/2 ml i.v.is administered at time of caecal intubation

DRUG

Saline 2 ml i.v.

Administration of Saline 2 ml at time of caecal intubation

Sponsors & Collaborators

  • Valduce Hospital

    lead OTHER

Principal Investigators

  • Spinzi Giancarlo, MD · Gastroenterology Unit, Ospedale Valduce, Como, Italy.

  • Franco Radaelli, MD · Gastroenterology Unit, Ospedale Valduce, Como. Italy.

  • Emanuele Rondonotti, MD · Gastroenterology Unit, Ospedale Valduvce, Como. Italy.

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01609855 on ClinicalTrials.gov